Hologic Inc.

Hologic is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, surgical products and light-based aesthetic and medical treatment systems. The company's segments are: Diagnostics, which provides diagnostic products which are used to aid in the diagnosis of human diseases; Breast Health, which provides solutions for breast cancer care for radiology, pathology and surgery; Medical Aesthetics, which provides aesthetic treatment systems, including SculpSure, PicoSure and MonaLisa Touch; GYN Surgical, which includes NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; and Skeletal Health, which includes the Horizon DXA, a dual energy x-ray system.
  • TickerHOLX
  • ISINUS4364401012
  • ExchangeNASDAQ Stock Market
  • SectorHealth Care Equipment & Services
  • CountryUnited States
Valens Research
  • Valens Research
HOLX HOLOGIC INC. (Health Care)

HOLX - Embedded Expectations Analysis - 2021 06 14

Hologic, Inc. (HOLX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with a 12.8x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, but management is confident about revenue growth targets, their business momentum, and Panther placements Specifically, management is confident they can grow by more than 5% annually in the long-run, that they expect 18%-26% year-over-year revenue growth, and that their business momentum and recovery will help generate strong revenue growth. Additionally, they are confident their Panth...

HOLX HOLOGIC INC. (Health Care)

Hologic, Inc. - March 2021 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Valens Research
  • Valens Research
HOLX HOLOGIC INC. (Health Care)

HOLX - Embedded Expectations Analysis - 2021 03 26

Hologic, Inc. (HOLX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with an 11.5x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, and management may have concerns about their organic revenue growth targets, recent acquisitions, and the sustainability of COVID testing demand Specifically, may lack confidence in their ability to sustain strong global sales performance, meet their organic revenue growth targets, and grow simultaneously across their three largest segments. Furthermore, they may have concerns about s...

HOLX HOLOGIC INC. (Health Care)

Hologic, Inc. - September 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers

Valens Research
  • Valens Research
HOLX HOLOGIC INC. (Health Care)

HOLX - Embedded Expectations Analysis - 2020 12 29

Hologic, Inc. (HOLX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with a 12.5x Uniform P/E. At these levels, the market has bearish expectations for the firm, and management may have concerns about COVID-19 testing production and demand, and the potential of the Breast Health segment Specifically, management may lack confidence in their ability to ramp COVID-19 test production, and they may have concerns about the sustainability of COVID-19 testing demand. Finally, management may be exaggerating the potential of the Breast Health and Surgical segment...

Valens Research
  • Valens Research
HOLX HOLOGIC INC. (Health Care)

HOLX - Embedded Expectations Analysis - 2021 06 14

Hologic, Inc. (HOLX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with a 12.8x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, but management is confident about revenue growth targets, their business momentum, and Panther placements Specifically, management is confident they can grow by more than 5% annually in the long-run, that they expect 18%-26% year-over-year revenue growth, and that their business momentum and recovery will help generate strong revenue growth. Additionally, they are confident their Panth...

HOLX HOLOGIC INC. (Health Care)

Hologic, Inc. - March 2021 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Valens Research
  • Valens Research
HOLX HOLOGIC INC. (Health Care)

HOLX - Embedded Expectations Analysis - 2021 03 26

Hologic, Inc. (HOLX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with an 11.5x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, and management may have concerns about their organic revenue growth targets, recent acquisitions, and the sustainability of COVID testing demand Specifically, may lack confidence in their ability to sustain strong global sales performance, meet their organic revenue growth targets, and grow simultaneously across their three largest segments. Furthermore, they may have concerns about s...

HOLX HOLOGIC INC. (Health Care)

Hologic, Inc. - September 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers

Valens Research
  • Valens Research
HOLX HOLOGIC INC. (Health Care)

HOLX - Embedded Expectations Analysis - 2020 12 29

Hologic, Inc. (HOLX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with a 12.5x Uniform P/E. At these levels, the market has bearish expectations for the firm, and management may have concerns about COVID-19 testing production and demand, and the potential of the Breast Health segment Specifically, management may lack confidence in their ability to ramp COVID-19 test production, and they may have concerns about the sustainability of COVID-19 testing demand. Finally, management may be exaggerating the potential of the Breast Health and Surgical segment...

Valens Research
  • Valens Research
HOLX HOLOGIC INC. (Health Care)

HOLX - Embedded Expectations Analysis - 2021 06 14

Hologic, Inc. (HOLX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with a 12.8x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, but management is confident about revenue growth targets, their business momentum, and Panther placements Specifically, management is confident they can grow by more than 5% annually in the long-run, that they expect 18%-26% year-over-year revenue growth, and that their business momentum and recovery will help generate strong revenue growth. Additionally, they are confident their Panth...

HOLX HOLOGIC INC. (Health Care)

Hologic, Inc. - March 2021 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Valens Research
  • Valens Research
HOLX HOLOGIC INC. (Health Care)

HOLX - Embedded Expectations Analysis - 2021 03 26

Hologic, Inc. (HOLX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with an 11.5x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, and management may have concerns about their organic revenue growth targets, recent acquisitions, and the sustainability of COVID testing demand Specifically, may lack confidence in their ability to sustain strong global sales performance, meet their organic revenue growth targets, and grow simultaneously across their three largest segments. Furthermore, they may have concerns about s...

HOLX HOLOGIC INC. (Health Care)

Hologic, Inc. - September 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers

Valens Research
  • Valens Research
HOLX HOLOGIC INC. (Health Care)

HOLX - Embedded Expectations Analysis - 2020 12 29

Hologic, Inc. (HOLX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with a 12.5x Uniform P/E. At these levels, the market has bearish expectations for the firm, and management may have concerns about COVID-19 testing production and demand, and the potential of the Breast Health segment Specifically, management may lack confidence in their ability to ramp COVID-19 test production, and they may have concerns about the sustainability of COVID-19 testing demand. Finally, management may be exaggerating the potential of the Breast Health and Surgical segment...

Valens Research
  • Valens Research
HOLX HOLOGIC INC. (Health Care)

HOLX - Embedded Expectations Analysis - 2021 06 14

Hologic, Inc. (HOLX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with a 12.8x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, but management is confident about revenue growth targets, their business momentum, and Panther placements Specifically, management is confident they can grow by more than 5% annually in the long-run, that they expect 18%-26% year-over-year revenue growth, and that their business momentum and recovery will help generate strong revenue growth. Additionally, they are confident their Panth...

HOLX HOLOGIC INC. (Health Care)

Hologic, Inc. - March 2021 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Valens Research
  • Valens Research
HOLX HOLOGIC INC. (Health Care)

HOLX - Embedded Expectations Analysis - 2021 03 26

Hologic, Inc. (HOLX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with an 11.5x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, and management may have concerns about their organic revenue growth targets, recent acquisitions, and the sustainability of COVID testing demand Specifically, may lack confidence in their ability to sustain strong global sales performance, meet their organic revenue growth targets, and grow simultaneously across their three largest segments. Furthermore, they may have concerns about s...

HOLX HOLOGIC INC. (Health Care)

Hologic, Inc. - September 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers

Valens Research
  • Valens Research
HOLX HOLOGIC INC. (Health Care)

HOLX - Embedded Expectations Analysis - 2020 12 29

Hologic, Inc. (HOLX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with a 12.5x Uniform P/E. At these levels, the market has bearish expectations for the firm, and management may have concerns about COVID-19 testing production and demand, and the potential of the Breast Health segment Specifically, management may lack confidence in their ability to ramp COVID-19 test production, and they may have concerns about the sustainability of COVID-19 testing demand. Finally, management may be exaggerating the potential of the Breast Health and Surgical segment...

Valens Research
  • Valens Research
HOLX HOLOGIC INC. (Health Care)

HOLX - Embedded Expectations Analysis - 2021 06 14

Hologic, Inc. (HOLX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with a 12.8x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, but management is confident about revenue growth targets, their business momentum, and Panther placements Specifically, management is confident they can grow by more than 5% annually in the long-run, that they expect 18%-26% year-over-year revenue growth, and that their business momentum and recovery will help generate strong revenue growth. Additionally, they are confident their Panth...

HOLX HOLOGIC INC. (Health Care)

Hologic, Inc. - March 2021 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Valens Research
  • Valens Research
HOLX HOLOGIC INC. (Health Care)

HOLX - Embedded Expectations Analysis - 2021 03 26

Hologic, Inc. (HOLX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with an 11.5x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, and management may have concerns about their organic revenue growth targets, recent acquisitions, and the sustainability of COVID testing demand Specifically, may lack confidence in their ability to sustain strong global sales performance, meet their organic revenue growth targets, and grow simultaneously across their three largest segments. Furthermore, they may have concerns about s...

HOLX HOLOGIC INC. (Health Care)

Hologic, Inc. - September 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers

Valens Research
  • Valens Research
HOLX HOLOGIC INC. (Health Care)

HOLX - Embedded Expectations Analysis - 2020 12 29

Hologic, Inc. (HOLX:USA) currently trades below recent averages relative to UAFRS-based (Uniform) earnings, with a 12.5x Uniform P/E. At these levels, the market has bearish expectations for the firm, and management may have concerns about COVID-19 testing production and demand, and the potential of the Breast Health segment Specifically, management may lack confidence in their ability to ramp COVID-19 test production, and they may have concerns about the sustainability of COVID-19 testing demand. Finally, management may be exaggerating the potential of the Breast Health and Surgical segment...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch